Integrated Cancer Research Foundation – Kenya
Integrated Cancer Research Foundation - Kenya
Evidence Based Research & Awareness
Webinar
Towards early detection of pancreatic cancer: SPECT/CT imaging of p53
Event summary:
Dr. Alakonya will present on his newly developed imaging agent to aid in the early diagnosis and prognosis evaluation of pancreatic cancer.
Speaker:
HUdson Alakonya, Ph.D
CEO - Integrated Cancer Research Foundation of Kenya.
Postdoctoral Fellow at Tuveson Lab, Cold Spring Harbor Laboratory, New York, USA,
Webinar Details
DATE: Saturday 13th July 2024
TIME: 4:00 - 5:30 PM (East Africa Time)
Meeting Link:
Event Description:
In this seminar, Hudson Alakonya will be presenting the results of his PhD project where he focused on developing a novel monoclonal antibody radiolabelled with a radioisotope as a single photon emission computed tomography (SPECT) imaging agent to aid in the early diagnosis and prognosis evaluation of PDAC patients. Hudson’s work has led to the development of the first successful radionuclide imaging agent for interrogating p53 protein in living tissues (in vivo).
You must be logged in to post a comment.